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Background: Exercise causes a variety of physiological and metabolic changes that can in turn reduce exercise
tolerance. One of the potential mechanisms responsible for fatigue is “exercise-induced hyperammonemia”.
Previous studies have shown that supplementation with amino acids can increase training tolerance. The α-keto
acids are biochemical analogs of amino acids and can be converted to amino acids through transamination, thus
reducing the cellular ammonia level. This double blind, placebo-controlled study was designed to investigate the
effects of α-keto acid supplementation (KAS) on training tolerance, training effect, and stress-recovery state.
Methods: Thirty-three untrained young male adults underwent four weeks of training (5 sessions/week; 30 minutes
running at the individual anaerobic threshold followed by 3 x 3 minute sprints/each session). Throughout the
4 weeks of training and one week of recovery, subjects took α-ketoglutarate (AKG group, 0.2 g/kg/d, n = 9),
branched-chain keto acids (BCKA group, 0.2 g/kg/d, n = 12) or isocaloric placebo (control group, n = 12) daily.
Results: The 4th week training volume, maximum power output and muscle torque were higher in the AKG group
(175 ± 42 min, 412 ± 49 Watts and 293 ± 58 Newton meters, respectively, P<0.05) and the BCKA group (158 ± 35,
390 ± 29 and 273 ± 47, P<0.05) than in the control group (92 ± 70, 381 ± 67 and 233 ± 43). The general stress and
emotional exhaustion as assessed by the rest-stress-questionnaire-sport after the 3rd week of training increased
significantly in the control group (P<0.05), but not in the KAS groups.
Conclusions: Under KAS, subjects could bear a higher training volume and reach a higher power output and peak
muscle torque, accompanied by a better stress-recovery-state. Thus, KAS improves exercise tolerance and training
effects along with a better stress-recovery state. Whether the improved training tolerance by KAS is associated with
effects on ammonia homeostasis requires further observation.Background
Physical exercise causes diverse physiological challenges,
including mechanical strain of the skeletal muscle [1]
and molecular responses [2,3], as well as metabolic
changes. Among the metabolic changes induced by exer-
cise, blood lactate concentration has been extensively
investigated [4,5]. It is well-known that protein break-
down is accelerated with intensive exercise [6]. Under
high-intensity exercise, amino acids produced from
muscle protein breakdown are partly used to produce
energy [7]. It has been shown that the blood level of* Correspondence: yuefei.liu@uniklinik-ulm.de
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reproduction in any medium, provided the orammonia increased significantly in rats during resistance
exercise and in humans during intense dynamic exercise
[8,9]. Several studies have reported that an exercise bout
causes a dramatic increase in ammonia concentration
along with an increase in inosine-5´-monophosphate
(IMP) and the ratio of IMP/AMP (adenosine monopho-
sphate), demonstrating a deamination process from
AMP to IMP under high energy turnover [10], which
can remain above the baseline level after one hour of
recovery [9]. Previous studies have attributed exercise-
induced hyperammonemia to fatigue [11,12]. Therefore,
an ammonia accumulation caused by exercise is con-
sidered a negative factor for exercise tolerance.
The effects of nutritional intervention, especially
amino acid supplements, on physical performance haveThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Basic data of the study subjects (mean± SD)*
Group n Age (years) Body mass (kg) Height (cm) BMI (kg/m²)
Control 12 25.2 ± 6.4 75.9 ± 8.3 179.1 ± 4.9 23.7 ± 2.9
AKG 9 26.7 ± 4.8 81.6 ± 12.7 178.3 ± 8.1 25.6 ± 2.5
BCKA 12 25.1 ± 6.8 78.6 ± 7.5 181.1 ± 4.8 23.9 ± 1.9
BMI: Body mass index = body mass (kg) / (body height in meters)²; AKG: α-keto
glutarate;
BCKA: Branched-chain keto acids. * No significant difference between the
groups.
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with specific amino acids, such as glutamate, reduces
ammonia concentrations during exercise [14]. However,
it is also evident that supplementation with branched-
chain amino acids (BCAA) leads to a distinct elevation
in arterial ammonia level during 60 min of exercise
[15]. Alternatively, α-keto acids that are analogs to
amino acids do not donate ammonia during metabol-
ism, but can catch or re-bind ammonia through the
ammonia-shuttle or recycle function [16]. For example,
α-ketoglutarate (AKG), re-binds ammonia through the
action of aminotransferase to form glutamate, and
the branched-chain keto acid (BCKA) to form BCAA
(the so-called BCKA-BCAA cycle) [16]. As a result,
α-keto acids, by exerting biological roles in protein
metabolism, may prevent or attenuate the hyperam-
monemia associated with physical training [17].
Previous studies of nutritional interventions with sup-
plementation of amino acids during physical training
have been published. BCAA supplementation was
reported to increase endurance capacity in trained indi-
viduals [18,19], but this result was not supported by
other studies [20,21]. In addition, the combination of the
keto analog and amino acid supplementation was
reported to attenuate the increase in blood ammonia
concentration after an exercise bout [8,22]. However,
studies of the effects of α-keto acid supplementation
(KAS) seem to be principally limited to pathological
conditions such as renal or hepatic disorders, and the
effects of KAS alone on physical exercise in healthy sub-
jects remain unknown. Because glutamate/glutamine
and BCAA play the prominent roles in protein metabol-
ism and have been extensively investigated [23-25],
examining the effects of their keto acid analogs
(i.e., AKG and BCKA) on physical training is of scientific
interest. We hypothesized that KAS can improve train-
ing tolerance under physiological conditions through its
biochemical role as an amino acid analog, but without
ammonia loading. This study was aimed to investigate
the effects of KAS on exercise tolerance, training effect,
and stress-recovery state in normal healthy subjects in a
double-blind, randomized, placebo-controlled trial.
Methods
Subjects
Thirty-six healthy male volunteers were initially enrolled
in the study. The health status of the subjects was veri-
fied by medical history, physical examination, electrocar-
diogram, echocardiogram, lung function test with body
plethysmogram and routine blood tests (full blood
counts, creatine kinase, aspartate transaminase, alanine
transaminase, and alkaline phosphatase, as well as elec-
trolytes, glucose, cholesterol and triglycerides) according
to the standards of German Society of Sports Medicine.Subjects with obesity, diabetes mellitus, cardiovascular
diseases and maple syrup urine disease were excluded.
The untrained status of the subjects was considered
when the following criteria were all met: physical exer-
cise had not been regular and was less than 2 hours
each week during the last three years, and maximum
oxygen uptake (VO2max) was < 50 mlmin1kg-1. After
giving informed consent, the subjects were randomized
(randomization was generated by the software package
SPSS, IBM, USA) into three groups, according to the
type of nutritional intervention. Thirty-three subjects
completed the study, while three subjects dropped out
of the study: one due to his business travel and two who
suffered ankle injuries at the beginning of the training
due to uneven running tracks. The general information
of the subjects is summarized in Table 1. This study
was approved by the Ethics Committee of the Medical
Faculty of the University of Ulm (Ulm, Germany).
Study design and protocol
The basic design of this study was a double blind, rando-
mized, placebo-controlled trial. After recruitment, the
subjects were randomized into the three groups. Obser-
vations were made before and after the training as well
as after the recovery. Blood samples were collected
1 week after nutritional supplementation (for medical
monitoring). The diet of the subjects was not manipu-
lated but was well documented and analyzed with the
software package PRODI (Freiburg, Germany) [26]. The
details are described as follows (Figure 1).
Physical training
The goal of the physical training was to challenge energy
metabolism by achieving an “over-reaching” training
level [27]. Two parts of physical training were included
in each training session: a 30 minute endurance run fol-
lowed by 3 x 3 minute sprints (maximum speed of the
subjects, heart rate ≥ 95% of the maximum on treadmill
test). The intensity of the endurance training was set
according to the heart rate at the individual anaerobic
threshold (IAT) [4] as determined by a treadmill test
(see below). The training program was four weeks long
with five sessions each week, under supervision. The
training was carefully documented and training time was
Figure 1 Study protocol. After receipt of the informed consent from the subjects, measurements of study parameters were performed at time
point 1, 2 and 3. After approximately 1 week of α-keto acid supplement (KAS), blood samples were collected for medical monitoring.
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went a one-week recovery. During the recovery phase,
no exercise was enforced except for daily life activities.Supplement of α-keto acids
According to the randomization, the subjects took one
of the following supplement mixes in granules (~ 2 mm
in diameter). The materials for KAS were kindly donated
by Evonik Rexim SAS (France) and were packed in small
bags containing the individual daily dose for each sub-
ject. KAS was orally (with water) given each day over
the period from training to the end of the recovery
week (5 weeks). The subjects were instructed to take
KAS within the time interval two hours before and two
hours after training or 16:00 – 20:00 hours on the non-
training days. A protocol for KAS, including compliance
or complaints, was documented every day by an assistant
of the study team.
Mix 1: AKG (0.2 gkg-1d-1), prepared with Na-AKG
144.66 mgkg-1d-1 (correspondingly 127.60 AKG
mgkg-1d-1) and Ca-AKG 91.33 mgkg-1d-1 (correspond-
ingly 72.40 mgkg-1d-1 AKG).
Mix 2: BCKA (0.2 gkg-1d-1), composed of three com-
ponents (α-ketoisocaproate, KIC, 47.4%; α-ketoisovalerate,
KIV, 30.0% and α-ketomethylvalerate, KMV, 22.6%), pre-
pared as follows: Na-KIC: 111.47 mgkg-1d-1 (correspond-
ingly KIC 94.80 mgkg-1d-1), Ca-KIV: 69.73 mgkg-1d-1
(correspondingly KIV 60.00 mgkg-1d-1), Ca-KMV:
52.40 mgkg-1d-1 (correspondingly 45.20 mgkg-1d-1).
Mix 3: Placebo of equivalent energy and sodium, as
well as calcium salts of the same appearance as AKG
and BCKA, composed of 235 mgkg-1d-1 glucose,
41.09 mgkg-1d-1 CaCO3, 38.02 mgkg-1d-1 NaHCO3.Determination of the study parameters
Observations were made at three points (Figure 1): be-
fore the training as the baseline (Test 1), after the four
weeks of training (Test 2) and at the end of one week of
recovery (Test 3). The following parameters were
determined.
The weekly training time was calculated for both en-
durance running and sprint running, according to the
training protocol (Figure and Table 2).VO2max: an exercise test was undertaken on a cycle-
ergometer (Lode Excalibur, Lode Company, Netherlands)
with the rapid ramp protocol (rapid linear increment at
40 Wattsmin-1) until the subject was exhausted. The
oxygen uptake was measured breath-by-breath using a
Metamax 3B (Cortex Company, Germany). Maximum
power output (Pmax) and VO2max were derived from
this test.
Running performance at the IAT [4] was determined
by a standard treadmill test (incline 1.5%, beginning at
6 kmh-1, increment 2 kmh-1 every 3 min) until the sub-
ject was exhausted. Performance at the IAT (PIAT) was
calculated from the relationship between power output
and changes in blood lactate concentration [4].
The isometric maximum torque (Tmax_ISM) and isokin-
etic maximum performance (Pmax_ISK) of the quadriceps
femoris of the dominant leg were determined using an
Isokinetic BIODEX Dynamometer (Biodex Medical Sys-
tems, USA); the maximum value was taken from three
attempts. Tmax_ISM was tested with the knee extension at
position 90°, and Pmax_ISK with the start position at 90°
and 60°s-1 rotation, according to the manufacturer’s
instructions.
Stress and recovery state
To monitor status and changes in stress and recovery of
the subjects during the study period, a recovery-stress
questionnaire (RESTQ-Sport) was used. The RESTQ-
Sport was specifically developed to measure the frequency
of current stress and recovery-associated activities, and
the German version of the RESTQ-Sport consists of 76
items (19 scales with four items each). A Likert-type scale
was used, with values ranging from 0 (never) to 5 (always)
(for the details please refer to [28]). The questionnaires
were completed weekly by the subjects.
Data analysis and statistics
All data are expressed as the mean ± SD; a P<0.05 was
considered as statistically significant, using an analysis of
variance with a post-hoc Scheffé test.
Results
During the study, no complaints or complications
related to KAS were reported. No pathological changes




Endurance training week 1 144 ± 12 143 ± 13 146 ± 14
week 2 130 ± 25 127 ± 33 140 ± 15
week 3 112 ± 48* 147 ± 10 127 ± 47
week 4 74 ± 54** 137 ± 30†† 122 ± 27††
sprint running week 1 44 ± 6 42 ± 4 42 ± 6
week 2 35 ± 8 37 ± 12 40 ± 6
week 3 30 ± 17 41 ± 5 34 ± 15
week 4 19 ± 17** 39 ± 12†† 35 ± 8†
VO2max (mlmin-1kg-1) before training 45.6 ± 7.3 47.1 ± 6.9 45.4 ± 5.1
after training 52.3 ± 6.2{{ 52.1 ± 7.2{{ 51.3 ± 5.2{{
after recovery 51.9 ± 8.3{{ 52.6 ± 7.1{{ 51.1 ± 5.1{{
Pmax (Watts) before training 365 ± 63 380 ± 59 369 ± 34
after training 377 ± 61 381 ± 56 374 ± 46
after recovery 381 ± 67 412 ± 49{ 390 ± 29{
PIAT (km/h) before training 9.6 ± 1.7 9.8 ± 2.2 9.9 ± 1.5
after training 10.8 ± 1.7{ 10.6 ± 1.7{ 10.6 ± 1.6{
after recovery 10.5 ± 1.7 10.2 ± 2.1 10.4 ± 1.4
AKG: α-keto glutarate; BCKA: branched-chain keto acids; min/w: training time in minutes each week; VO2max: the maximum oxygen uptake measured on the
cycle-ergometry; Pmax: the maximum power output on the cycle-ergometry; PIAT: the performance at the individual lactate threshold determined by treadmill test;
Tmax_ISM: the maximum muscle torque by isometric measurement; Pmax_ISK: the maximum muscle performance by isokinetic measurement.
* P<0.05 compared with that of 1st week; ** P<0.01 compared with that of 1st week; † P<0.05 compared with that of the control group; †† P<0.01 compared with
that of the control group; { P<0.05 compared with that before training; {{ P<0.01 compared with that before training.
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clinical laboratory parameters. The subjects’ compli-
ance with taking the nutritional supplement was satis-
factory (98.3%).
The diet was comparable among the different groups
and did not change throughout the study period (total
caloric intake: 2509 ± 115 kcald-1, of which carbohy-
drates composed 49.2%; fat 30.3%; protein 17.1% and al-
cohol 3.4%).
Metabolic parameters, including BMI, body fat per-
centage (15.9 ± 0.7%) measured by infrared spectrometer,
blood concentration of glucose (4.7 ± 0.1 mmoll-1), chol-
esterol (4.3 ± 0.1mmoll-1), triglyceride (1.6 ± 0.1 mmoll-1)
and C-reactive protein (0.8 ± 0.1 mgl-1), were similar
among the different groups.
Training
The training data are summarized in Table 2 and
Figures 2, 3 and 4. During the first two weeks of train-
ing, the total training time, training times for endurance
and for sprint running did not differ significantly
among the groups. However, from the third week on-
wards all training times decreased in the control group
(P<0.05), while they remained essentially unchanged inthe AKG group and the BCKA group (Figure 2). Thus,
the training volume in the second half of the training
phase was clearly lower in the control group than in
the AKG and the BCKA groups (P<0.05).
The VO2max increased significantly after training and
during recovery in all three groups (P<0.01), and there
was no significant difference among the three groups at
each test time point. The Pmax increased in the groups
supplemented with KAS after the recovery period com-
pared with that before training (P<0.05), while the in-
crease in Pmax in the control group was less and was not
statistically significant. The endurance capacity assessed
by PIAT was increased at the end of training in all three
groups, but no statistically significant difference was
observed among the groups.
The muscle function tests showed that the isometric
maximum torque was different at the baseline level
among the groups, but the difference was not statisti-
cally significant (P = 0.27). The torque did not change in
the control group after training and recovery, but it
increased significantly after the recovery week (P<0.05)
in the AKG and BCKA groups (Figure 3). Similar
results were observed in muscle performance as
assessed by the isokinetic measurement (Figure 4). The
Figure 2 The total training time (minutes) each week in mean± SD (endurance training time+ sprint running time). AKG: α-keto
glutarate; BCKA: branched-chain keto acids.
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among the groups, but the difference was not statistically
significant (P= 0.144).Stress-recovery state
In the RESTQ-Sport analysis, the general stress was
markedly increased in the control group during the third
week of the training (P<0.05) (Figure 5a), and it did not
change in BCKA group (NS). In the AKG group, the
general stress was higher at baseline than in the other
groups, but it did not change significantly during the
study period (NS).
For the somatic complaints (Figure 5b), the baseline
RESTQ-scores in the control group were higher (but not
statistically significant) than in the other groups. These
values were essentially unchanged during the entire ob-
servation period in the control group, while increasing
in the AKG group (P<0.05) and in the BCKA group
(P<0.01) during the training phase.Figure 3 The peak maximal isometric torque (Newton meter) in meanEmotional exhaustion assessed by RESTQ-scores
increased and reached the highest level during the third
week of the training in the control group (P<0.01)
(Figure 5c) but did not change significantly in the
BCKA group (NS). In the AKG group, it was elevated
during the last three weeks of the training as well as
after the recovery compared with the before-training
scores (P<0.05).
The RESTQ-scores for the disturbed breaks increased
from the 1st to the 3rd week of training (P<0.05), and
then decreased gradually in the control group
(Figure 5d). There was no change in the AKG or the
BCKA group during the observation period, although
there were more disturbed breaks in the AKG group
than in the BCKA group.
Discussion
Physical exercise causes a variety of physiological
changes that in turn impact exercise tolerance. An accu-
mulation of metabolites such as ammonia produced by±SD. AKG: α-keto glutarate; BCKA: branched-chain keto acids.
Figure 4 The peak isokinetic performance (Watts) in mean± SD. AKG: α-keto glutarate; BCKA: branched-chain keto acids.
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olism during exercise may play an important role in
this regard. Any modification to metabolites may affect
exercise tolerance. Previous studies have shown thatFigure 5 The weekly data from the recovery-stress questionnaire (RES
emotional exhaustion (C) and disturbed breaks (D). AKG: α-keto glutara
RESTQ-Scores 5: always.supplementation with amino acids can lead to changes in
energy metabolites and physical performance [18,29-32].
Biochemically, α-keto acids are endogenous intermedi-
ate metabolites, analogs to amino acids and may affectTQ-scores) for general stress (A), somatic complaints (B),
te; BCKA: branched-chain keto acids. RESTQ-Scores 0: never;
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Therefore, it is likely that supplementation with α-keto
acids has an impact on physical training. We have
therefore hypothesized that supplementation with
α-keto acids improves exercise tolerance and training
effects. In this study, we found that by supplementing
the subjects with KAS, their training volume, max-
imum power output and maximum muscle torque, as
well as their performance, were all significantly
increased, which was associated with a better recovery-
stress state. Therefore, KAS can indeed improve train-
ing tolerance.
KAS effects on physical training
A number of studies of nutritional intervention during
physical training have been published. A recent study
reported that acute supplementation of cyclists with keto
analogs and amino acids during exercise attenuated
exercise-induced hyperammonemia [22]. However, the
effects of KAS alone during prolonged physical training
have not been reported. In the present study, we have
adopted the double blind, randomized and placebo-
controlled trial design, so that the subjective component
affecting exercise tolerance could be precluded from the
effects of KAS. To provoke the metabolic challenge, a
cohort of untrained subjects was recruited and a very
strenuous training program was undertaken to achieve
an “over-reaching” status. The training was highly
demanding; the subjects in the control group could not
maintain their assigned training volume during the sec-
ond half of the program (Table 2, Figure 2, 3 and 4). The
training data also showed a typical training effect at the
stage of over-reaching; i.e., a significant improvement in
maximum power output after recovery but only slightly
in aerobic exercise capacity, as previously reported [37].
The subjects underwent an endurance-training bout first
so that the energy reserve was exhausted, and the subse-
quent sprint running would then draw energy partly
from protein metabolism. This training strategy consti-
tutes a valid metabolic challenge [6]. To exclude the in-
fluence of components other than α-keto acids, the
intake of energy and minerals was carefully matched in
the placebo preparation. There were no side effects or
difficulties in compliance, suggesting that the supple-
mentation was safe.
Despite the hard training, over-training did not occur
because there were no clinical complaints and no de-
crease in the maximum performance and maximum
blood lactate concentration (10.7 ± 2.4 mM). The train-
ing, however, improved VO2max (average 14%, P<0.01) in
all three groups (Table 2). This result is in accord with
those of other studies [38]. The training effect on
VO2max was comparable among the three groups, al-
though the training volume was quite different at thesecond half of the training phase. This finding may be
explained by the fact that the oxygen delivery deter-
mined principally by the cardiorespiratory system is the
primary limiting factor for VO2max [39]. The maximum
power output did not change in the control group after
the training phase and recovery (NS). There was a simi-
lar increase in maximum power output in both study
groups after the training and more so after recovery, in-
dicating a “super-compensation” effect from training
(Table 2). These results are in good accord with those of
previous studies [40], and suggest a significant training
effect in both groups supplemented with KAS. Similarly,
the muscle function, both maximum torque on isometric
measurement and maximum performance on isokinetic
measurement, increased significantly after recovery in
both groups supplemented with KAS. The maximum
muscle torque was higher in the AKG group than in the
BCKA group (Figure 3), mainly due to the different
baseline levels but not changes in training (NS). In the
present study, the endurance capacity (PLAT in Table 2)
was improved in all three groups with no significant dif-
ference among the groups, which could be attributed to
the concurrent training program executed with com-
bined training components [41].
It is also interesting to observe the relative changes in
VO2max and Pmax.. There was a similar increase in
VO2max in all three groups, but the Pmax was much
higher in the two groups with KAS than in the control
group, suggesting that there was either a higher work ef-
ficiency or a higher quotient of anaerobic energy metab-
olism associated with KAS. Because the maximum blood
lactate concentration was comparable among the groups
(data not shown), the higher relation of Pmax to VO2max
for both groups with KAS can be considered as reflect-
ing improved work efficiency.
VO2max was determined on a cycle-ergometer instead
of using a treadmill test since this method was estab-
lished in our laboratory and a rapid linear increment of
the workload was better to achieve. Determination of
VO2max on a cycle-ergometer is well established and
widespread in the routine practice of sports medicine.
Yet it remains unclear whether a lack of statistically sig-
nificant difference in this parameter among the groups
could be attributed to the known fact that VO2max deter-
mined on a cycle-ergometer is generally lower than that
determined on a treadmill [42,43].
In summary, the training program performed in this
study produced distinct training effects in the control
group. However, KAS supplementation was associated
with additional improvements in Pmax and maximum
muscular torque and performance. Together with the
data from training volume, it can be concluded that
KAS improves training tolerance and has beneficial
effects on physical training.
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The state of stress-recovery during and after a training
phase can be assessed using the questionnaire RESTQ-
sport [28]. In general, the profiles of the RESTQ
scores were quite different among the three groups
(Figure 5A-D). The term general stress reached its high-
est level in the control group after the third training
week (Figure 5A). Emotional exhaustion (Figure 5C)
and a slight increase in somatic complaints (Figure 5B)
followed the same pattern but with distinct disturbed
breaks as a sign of poor recovery (Figure 5D). A de-
crease in the general stress parameters at the end of the
4th training week and after recovery was associated with
a reduction in training volume (Figure 2). This finding
is in agreement with those of Kellmann and Gunther,
who concluded that the general stress and somatic com-
plaints were correlated with the duration of intense
training [28]. In contrast with the results for the control
group, the RESTQ scores for the terms general stress
(Figure 5A) and emotional exhaustion (Figure 5C) in
the BCKA group did not change significantly and
remained at a lower level, but the somatic complaints
increased during the training period (Figure 5B). These
data suggest that BCKA supplements can relieve general
stress and emotional exhaustion and better preserve the
recovery after high-level exercise. With the AKG sup-
plement, the RESTQ profile was comparable to that of
the control group, although the training volume was
higher in the 3rd and 4th training weeks. Considering
the relationship between the amount of training and
RESTQ scores in general stress and somatic complaints
reported by Kellmann and Gunther [28], our data sug-
gest that supplementation with AKG helps maintain the
level of general stress, somatic complaints and emo-
tional exhaustion during high-intensity training.
To the best of our knowledge, there are no previous
studies investigating the effects of KAS supplementation
on physical training. However, two relevant studies have
been reported [8,22]. In a study of adult rats, De
Almeida et al. have shown that exercise increased am-
monia levels twofold with respect to the control and
significantly increased blood urea levels (17%). Those
authors also report that acute supplementation with
keto acid-associated amino acids (KAAA) clearly
reduced exercise-induced hyperammonemia [8]. This
result was supported by a study of male cyclists, where
it was observed that short-term supplementation with
KAAA blunted exercise-induced hyperammonemia [22].
However, in these two acute studies, the effect of
KAAA on exercise tolerance was not investigated.
Thus, whether the inhibition of exercise-induced hyper-
ammonemia by supplementation with KAAA leads to
an improvement in training tolerance remains unclear.
Although the underlying mechanism of the effects ofthe supplementation of α-keto acids on physical exer-
cise remains unclear, we have shown the beneficial im-
pact of the supplementation with KAS on physical
training in untrained individuals. Further studies are
needed to clarify whether KAS supplementation affects
amino acid homeostasis and ammonia metabolism dur-
ing and after physical exercise.
Conclusions
Physical exercise is of great significance to public health.
However, to maintain physical activity is by no means
simple, and exercise adherence is affected by a variety of
factors. Finding ways to modify inhibitory factors such
as exercise-induced hyperammonemia is of great scien-
tific and clinical interest. This study has shown that
nutritional supplementation with α-keto acids in
healthy, untrained subjects significantly improved exer-
cise tolerance, training effects, and stress-recovery state.
Therefore, observations to further verify the potential
benefits of α-keto acid supplements in subjects during
active training will be of scientific and clinical value.
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